Differential Sensitivity of Glioma- versus Lung Cancer-specific EGFR mutations to EGFR Kinase Inhibitors

Activation of the epidermal growth factor receptor (EGFR) in glioblastoma (GBM) occurs through mutations or deletions in the extracellular (EC) domain. Unlike lung cancers with EGFR kinase domain (KD) mutations, GBMs respond poorly to the EGFR inhibitor erlotinib. Using RNAi, we show that GBM cells...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vivanco, Igor, Robins, H. Ian, Rohle, Daniel, Campos, Carl, Grommes, Christian, Nghiemphu, Phioanh Leia, Kubek, Sara, Oldrini, Barbara, Chheda, Milan G., Yannuzzi, Nicolas, Tao, Hui, Zhu, Shaojun, Iwanami, Akio, Kuga, Daisuke, Dang, Julie, Pedraza, Alicia, Brennan, Cameron W., Heguy, Adriana, Liau, Linda M., Lieberman, Frank, Yung, W.K. Alfred, Gilbert, Mark R., Reardon, David A., Drappatz, Jan, Wen, Patrick Y., Lamborn, Kathleen R., Chang, Susan M., Prados, Michael D., Fine, Howard A., Horvath, Steve, Wu, Nian, Lassman, Andrew B., DeAngelis, Lisa M., Yong, William H., Kuhn, John G., Mischel, Paul S., Mehta, Minesh P., Cloughesy, Timothy F., Mellinghoff, Ingo K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3354723/
https://ncbi.nlm.nih.gov/pubmed/22588883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-11-0284
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados